A French Prospective, Observational Cohort Study of Patients With Fabry Disease Treated With Migalastat - the MIGA-FAB Study
Latest Information Update: 27 May 2024
At a glance
- Drugs Migalastat (Primary)
- Indications Fabry's disease
- Focus Adverse reactions; Therapeutic Use
- Acronyms MIGA-FAB
- Sponsors Amicus Therapeutics
- 22 May 2024 Status changed from active, no longer recruiting to completed.
- 26 Jul 2022 Status changed from recruiting to active, no longer recruiting.
- 28 Oct 2020 New trial record